We develop and commercialize innovative, clinically relevant diagnostic tools based on genetics.
Our products enable to:
Based on the most recent, validated knowledge in the field of health and genetics and proprietary algorithms.
14 September 2017
Gene Predictis®, in collaboration with the group of Prof. Zoltàn Kutalik at CHUV (University Hospital of Canton Vaud) and the SIB Swiss Institute of Bioinformatics, published a study concerning Pill Protect® test, an innovative medical test that uses genetic data …
7 November 2016
As of November 1st, 2016, Gene Predictis’ genetic tests Pill Protect® and Cypass® are reimbursed by supplementary healthcare cover PRIMEO from Helsana, the leading insurance group in Switzerland. These tests allow to evaluate, for every individual, the risk of adverse …